BioCentury | Nov 30, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: November 2017

...disease and amyotrophic lateral sclerosis (ALS). University of Bielefeld ; University Hospital Würzburg Distillery Therapeutics RAB26 member RAS oncogene family...
BioCentury | Nov 15, 2017
Distillery Therapeutics

Neurology

...could include identifying and testing RAB26 activators in models of PLEKHG5-mutant motor neuron disease. TARGET/MARKER/PATHWAY: RAB26 member RAS oncogene family...
...Würzburg, Germany email: Sendtner_M@ukw.de Hongjiang Li University Hospital Wuerzburg University of Bielefeld Pleckstrin homology and RhoGEF domain containing G5 (PLEKHG5) RAB26 member RAS oncogene family...
Items per page:
1 - 2 of 2